{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:29:46Z","timestamp":1775122186066,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-026-02305-3","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:37:48Z","timestamp":1774715868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Artificial intelligence and radiomics on computed tomography for differentiating hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a multimodal integration approach"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7251-7658","authenticated-orcid":false,"given":"Chen","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibo","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6347-7998","authenticated-orcid":false,"given":"Jingcheng","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"2305_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics, 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"2305_CR2","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.3390\/cancers13122871","volume":"13","author":"M Komuta","year":"2021","unstructured":"Komuta M. Histological heterogeneity of primary liver Cancers: clinical relevance, diagnostic pitfalls and the Pathologist\u2019s role. Cancers. 2021;13:2871. https:\/\/doi.org\/10.3390\/cancers13122871.","journal-title":"Cancers"},{"key":"2305_CR3","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrc4017","volume":"15","author":"JU Marquardt","year":"2015","unstructured":"Marquardt JU, Andersen JB, Thorgeirsson SS. Functional and genetic deconstruction of the cellular origin in liver cancer. Nat Rev Cancer. 2015;15:653\u201367. https:\/\/doi.org\/10.1038\/nrc4017.","journal-title":"Nat Rev Cancer"},{"key":"2305_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","volume":"161","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Ferlay J, De Martel C, Georges D, Ibrahim AS, Zheng R, et al. Global, regional and national burden of primary liver cancer by subtype. Eur J Cancer. 2022;161:108\u201318. https:\/\/doi.org\/10.1016\/j.ejca.2021.11.023.","journal-title":"Eur J Cancer"},{"key":"2305_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","volume":"82","author":"B Sangro","year":"2025","unstructured":"Sangro B, Argemi J, Ronot M, Paradis M V, Mazzaferro T V, et al. EASL clinical Practice Guidelines on the management of hepatocellular carcinoma. J Hepatol. 2025;82:315\u201374. https:\/\/doi.org\/10.1016\/j.jhep.2024.08.028.","journal-title":"J Hepatol"},{"key":"2305_CR6","unstructured":"Benson A, D\u2019Angelica BI, Michael I, Abrams T, Ahmed A, Akce M, et al. Hepatobiliary Cancers, version 1. 2025. NCCN Clin Pract Guidelines Oncol. 2025."},{"key":"2305_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.annonc.2025.02.006","volume":"36","author":"A Vogel","year":"2025","unstructured":"Vogel A, Chan SL, Dawson LA, Kelley RK, Llovet JM, Meyer T, et al. Hepatocellular carcinoma: ESMO clinical Practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2025;36:491\u2013506. https:\/\/doi.org\/10.1016\/j.annonc.2025.02.006.","journal-title":"Ann Oncol"},{"key":"2305_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","volume":"79","author":"D Alvaro","year":"2023","unstructured":"Alvaro D, Gores GJ, Walicki J, Hassan C, Sapisochin G, Komuta M, et al. EASL-ILCA clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma. J Hepatol. 2023;79:181\u2013208. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.010.","journal-title":"J Hepatol"},{"key":"2305_CR9","doi-asserted-by":"crossref","unstructured":"Benson A, D\u2019Angelica BI, Michael I, Abrams T, Ahmed A, Akce M, et al. Biliary tract Cancers, version 1. 2025. NCCN Clin Pract Guidelines Oncol. 2025.","DOI":"10.6004\/jnccn.2025.0042"},{"key":"2305_CR10","doi-asserted-by":"publisher","unstructured":"Liu X, Lu Y, Zhou W, Peng T, Zhou J, Bi H, et al. Chinese multidisciplinary expert consensus on immune checkpoint inhibitor-based combination therapy for hepatocellular carcinoma (2023 edition). Liver Cancer. 2024;13:355\u201375. https:\/\/doi.org\/10.1159\/000535496.","DOI":"10.1159\/000535496"},{"key":"2305_CR11","doi-asserted-by":"publisher","first-page":"100614","DOI":"10.1016\/j.currproblcancer.2020.100614","volume":"45","author":"M Fruscione","year":"2021","unstructured":"Fruscione M, Pickens RC, Baker EH, Martinie JB, Iannitti DA, Hwang JJ, et al. Conversion therapy for intrahepatic cholangiocarcinoma and tumor downsizing to increase resection rates: a systematic review. Curr Probl Cancer. 2021;45:100614. https:\/\/doi.org\/10.1016\/j.currproblcancer.2020.100614.","journal-title":"Curr Probl Cancer"},{"key":"2305_CR12","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/liv.12124","volume":"33","author":"M Galassi","year":"2013","unstructured":"Galassi M, Iavarone M, Rossi S, Bota S, Vavassori S, Rosa L, et al. Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound. Liver Int. 2013;33:771\u201379. https:\/\/doi.org\/10.1111\/liv.12124.","journal-title":"Liver Int"},{"key":"2305_CR13","doi-asserted-by":"publisher","first-page":"26772","DOI":"10.1038\/srep26772","volume":"6","author":"R Li","year":"2016","unstructured":"Li R, Cai P, Ma K, Ding S-Y, Guo D-Y, Yan X-C. Dynamic enhancement patterns of intrahepatic cholangiocarcinoma in cirrhosis on contrast-enhanced computed tomography: risk of misdiagnosis as hepatocellular carcinoma. Sci Rep. 2016;6:26772. https:\/\/doi.org\/10.1038\/srep26772.","journal-title":"Sci Rep"},{"key":"2305_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1148\/radiol.2016151205","volume":"281","author":"B Huang","year":"2016","unstructured":"Huang B, Wu L, Lu X-Y, Xu F, Liu C-F, Shen W-F, et al. Small intrahepatic cholangiocarcinoma and hepatocellular carcinoma in cirrhotic livers may share similar enhancement patterns at multiphase Dynamic MR Imaging. Radiology. 2016;281:150\u201357. https:\/\/doi.org\/10.1148\/radiol.2016151205.","journal-title":"Radiology"},{"key":"2305_CR15","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1002\/hep.23600","volume":"51","author":"R Vilana","year":"2010","unstructured":"Vilana R, Forner A, Bianchi L, Garc\u00eda-Criado A, Rimola J, de Lope CR, et al. Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology. 2010;51:2020\u201329. https:\/\/doi.org\/10.1002\/hep.23600.","journal-title":"Hepatology"},{"key":"2305_CR16","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.2214\/ajr.07.2484","volume":"189","author":"SJ Kim","year":"2007","unstructured":"Kim SJ, Lee JM, Han JK, Kim KH, Lee JY, Choi BI. Peripheral mass-forming cholangiocarcinoma in Cirrhotic liver. Am J Roentgenol. 2007;189:1428\u201334. https:\/\/doi.org\/10.2214\/ajr.07.2484.","journal-title":"Am J Roentgenol"},{"key":"2305_CR17","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1136\/gut.2008.149062","volume":"57","author":"MA Silva","year":"2008","unstructured":"Silva MA, Hegab B, Hyde C, Guo B, Buckels JAC, Mirza DF. Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut. 2008;57:1592\u201396. https:\/\/doi.org\/10.1136\/gut.2008.149062.","journal-title":"Gut"},{"key":"2305_CR18","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.14309\/ajg.0000000000003210","volume":"120","author":"C Nie","year":"2024","unstructured":"Nie C, Vaska M, Wong JK, Bathe OF, Przybojewski S, Burak KW, et al. Tumor seeding with Needle biopsy of hepatocellular carcinoma: a systematic review. Am J Gastroenterol. 2024;120:1144\u201351. https:\/\/doi.org\/10.14309\/ajg.0000000000003210.","journal-title":"Am. J. Gastroenterol"},{"key":"2305_CR19","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.3748\/wjg.v25.i40.6041","volume":"25","author":"LD Tommaso","year":"2019","unstructured":"Tommaso LD, Spadaccini M, Donadon M, Personeni N, Elamin A, Aghemo A, et al. Role of liver biopsy in hepatocellular carcinoma. World J Gastroenterol. 2019;25:6041\u201352. https:\/\/doi.org\/10.3748\/wjg.v25.i40.6041.","journal-title":"World J Gastroenterol"},{"key":"2305_CR20","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.jhep.2022.01.014","volume":"76","author":"J Calderaro","year":"2022","unstructured":"Calderaro J, Seraphin TP, Luedde T, Simon TG. Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma. J Hepatol. 2022;76:1348\u201361. https:\/\/doi.org\/10.1016\/j.jhep.2022.01.014.","journal-title":"J Hepatol"},{"key":"2305_CR21","doi-asserted-by":"publisher","unstructured":"Bo Z, Song J, He Q, Chen B, Chen Z, Xie X, et al. Application of artificial intelligence radiomics in the diagnosis, treatment, and prognosis of hepatocellular carcinoma. Comput Biol Med. 2024;173:108337. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108337.","DOI":"10.1016\/j.compbiomed.2024.108337"},{"key":"2305_CR22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3348\/kjr.2024.0070","volume":"25","author":"S Heo","year":"2024","unstructured":"Heo S, Park HJ, Lee SS. Prognostication of hepatocellular carcinoma using Artificial intelligence. Korean J Radiol. 2024;25:550. https:\/\/doi.org\/10.3348\/kjr.2024.0070.","journal-title":"Korean J Radiol"},{"key":"2305_CR23","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/med.21846","volume":"42","author":"J Guiot","year":"2021","unstructured":"Guiot J, Vaidyanathan A, Deprez L, Zerka F, Danthine D, Frix A, et al. A review in radiomics: making personalized medicine a reality via routine imaging. Med Res Rev. 2021;42:426\u201340. https:\/\/doi.org\/10.1002\/med.21846.","journal-title":"Med Res Rev"},{"key":"2305_CR24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2025.04.017","volume":"83","author":"M Vithayathil","year":"2025","unstructured":"Vithayathil M, Koku D, Campani C, Nault J-C, Sutter O, Carri\u00e9 NG, et al. Machine learning based radiomic models outperform clinical biomarkers in predicting outcomes after immunotherapy for hepatocellular carcinoma. J Hepatol. 2025;83:959\u201370. https:\/\/doi.org\/10.1016\/j.jhep.2025.04.017.","journal-title":"J Hepatol"},{"key":"2305_CR25","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1158\/1078-0432.CCR-22-2784","volume":"29","author":"Z Bo","year":"2023","unstructured":"Bo Z, Chen B, Zhao Z, He Q, Mao Y, Yang Y, et al. Prediction of response to Lenvatinib Monotherapy for Unresectable hepatocellular carcinoma by machine learning radiomics: a multicenter cohort study. Clin Cancer Res. 2023;29:1730\u201340. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-2784.","journal-title":"Clin Cancer Res"},{"key":"2305_CR26","unstructured":"Python Software Foundation. The Python Language. 2024."},{"key":"2305_CR27","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","volume":"30","author":"A Fedorov","year":"2012","unstructured":"Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J-C, Pujol S, et al. 3D Slicer as an image computing platform for the quantitative imaging network. Magn Reson Imag. 2012;30:1323\u201341. https:\/\/doi.org\/10.1016\/j.mri.2012.05.001.","journal-title":"Magn Reson Imag"},{"key":"2305_CR28","unstructured":"3D Slicer image computing platform."},{"key":"2305_CR29","unstructured":"SlicerRadiomics. 2024."},{"key":"2305_CR30","unstructured":"Scikit-Learn: Machine Learning in Python."},{"key":"2305_CR31","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.7150\/ijbs.71046","volume":"18","author":"L Zhang","year":"2022","unstructured":"Zhang L, Wang Y, Peng Z, Weng Y, Fang Z, Xiao F, et al. The progress of multimodal imaging combination and subregion based radiomics research of cancers. Int J Biol Sci. 2022;18:3458\u201369. https:\/\/doi.org\/10.7150\/ijbs.71046.","journal-title":"Int J Biol Sci"},{"key":"2305_CR32","doi-asserted-by":"publisher","first-page":"103322","DOI":"10.1016\/j.ejmp.2024.103322","volume":"120","author":"S Wang","year":"2024","unstructured":"Wang S, Wang X, Yin X, Lv X, Cai J. Differentiating HCC from ICC and prediction of ICC grade based on MRI deep-radiomics: using lesions and their extended regions. Phys Med. 2024;120:103322. https:\/\/doi.org\/10.1016\/j.ejmp.2024.103322.","journal-title":"Phys Med"},{"key":"2305_CR33","doi-asserted-by":"publisher","unstructured":"Zhou M, Zhang P, Mao Q, Shi Y, Yang L, Zhang X. Multisequence MRI-Based radiomic features combined with inflammatory indices for predicting the overall survival of HCC patients after TACE. J Hepatocell Carcinoma. 2024;11:2049\u201361. https:\/\/doi.org\/10.2147\/JHC.S481301.","DOI":"10.2147\/JHC.S481301"},{"key":"2305_CR34","doi-asserted-by":"publisher","unstructured":"Zhang X, He Z, Zhang Y, Kong J. Prediction of initial objective response to drug-eluting beads transcatheter arterial chemoembolization for hepatocellular carcinoma using CT radiomics-based machine learning model. Front Pharmacol. 2024;15:1315732. https:\/\/doi.org\/10.3389\/fphar.2024.1315732.","DOI":"10.3389\/fphar.2024.1315732"},{"key":"2305_CR35","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1097\/JS9.0000000000002322","volume":"111","author":"Z Lin","year":"2025","unstructured":"Lin Z, Wang W, Yan Y, Ma Z, Xiao Z, Mao K. A deep learning-based clinical-radiomics model predicting the treatment response of immune checkpoint inhibitors (ICIs)-based conversion therapy in potentially convertible hepatocelluar carcinoma patients: a tumor marker prognostic study. Int J Surg. 2025;111:3342\u201355. https:\/\/doi.org\/10.1097\/JS9.0000000000002322.","journal-title":"Int J Surg"},{"key":"2305_CR36","doi-asserted-by":"publisher","unstructured":"Zhang X, Zhang Y, Zhang G, Qiu X, Tan W, Yin X, et al. Prospective clinical research of radiomics and deep learning in oncology: a translational review. Crit Rev Oncol Hematol. 2022;179:103823. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103823.","DOI":"10.1016\/j.critrevonc.2022.103823"},{"key":"2305_CR37","doi-asserted-by":"publisher","unstructured":"Phan TMN, Dao C-T, Wu C, Wang J-Z, Liu S, Ding J-E, et al. Medfuse: multimodal EHR data fusion with masked lab-test modeling and large Language models. 2024. https:\/\/doi.org\/10.48550\/arXiv.2407.12309.","DOI":"10.48550\/arXiv.2407.12309"},{"key":"2305_CR38","doi-asserted-by":"publisher","unstructured":"Kumar V, Gu Y, Basu S, Berglund A, Eschrich SA, Schabath MB, et al. Radiomics: the process and the challenges. Magn Reson Imag. 2012;30:1234\u201348. https:\/\/doi.org\/10.1016\/j.mri.2012.06.010.","DOI":"10.1016\/j.mri.2012.06.010"},{"key":"2305_CR39","unstructured":"Jiangtao W, Ruhaiyem NIR, Panpan F. A comprehensive review of U-Net and its variants: advances and applications in medical image segmentation."},{"key":"2305_CR40","doi-asserted-by":"publisher","unstructured":"Xu X, Zhang H-L, Liu Q-P, Sun S-W, Zhang J, Zhu F-P, et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol. 2019;70:1133\u201344. https:\/\/doi.org\/10.1016\/j.jhep.2019.02.023.","DOI":"10.1016\/j.jhep.2019.02.023"},{"key":"2305_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13244-019-0795-6","volume":"11","author":"R Lo Gullo","year":"2020","unstructured":"Lo Gullo R, Daimiel I, Morris EA, Pinker K. Combining molecular and imaging metrics in cancer: radiogenomics. Insights Imag. 2020;11:1. https:\/\/doi.org\/10.1186\/s13244-019-0795-6.","journal-title":"Insights Imag"},{"key":"2305_CR42","doi-asserted-by":"publisher","first-page":"2408069","DOI":"10.1002\/advs.202408069","volume":"12","author":"Y Guo","year":"2024","unstructured":"Guo Y, Li T, Gong B, Hu Y, Wang S, Yang L, et al. From images to genes: radiogenomics based on Artificial intelligence to achieve non-invasive precision medicine in cancer patients. Adv Sci. 2024;12:2408069. https:\/\/doi.org\/10.1002\/advs.202408069.","journal-title":"Adv Sci"},{"key":"2305_CR43","doi-asserted-by":"publisher","first-page":"167841","DOI":"10.1016\/j.bbadis.2025.167841","volume":"1871","author":"J Camps","year":"2025","unstructured":"Camps J, Jim\u00e9nez-Franco A, Garc\u00eda-Pablo R, Joven J, Arenas M. Artificial intelligence-driven integration of multi-omics and radiomics: a new hope for precision cancer diagnosis and prognosis. Biochim Biophys Acta BBA - Mol Basis Dis. 2025;1871:167841. https:\/\/doi.org\/10.1016\/j.bbadis.2025.167841.","journal-title":"Biochim Biophys Acta BBA - Mol Basis Dis"},{"key":"2305_CR44","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3350\/cmh.2018.1007","volume":"25","author":"WK Jeong","year":"2019","unstructured":"Jeong WK, Jamshidi N, Felker ER, Raman SS, Lu DS. Radiomics and radiogenomics of primary liver cancers. Clin Mol Hepatol. 2019;25:21\u201329. https:\/\/doi.org\/10.3350\/cmh.2018.1007.","journal-title":"Clin Mol Hepatol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-026-02305-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02305-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-026-02305-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T08:30:01Z","timestamp":1775118601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-026-02305-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2305"],"URL":"https:\/\/doi.org\/10.1186\/s12880-026-02305-3","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was conducted in accordance with the principles of the Declaration of Helsinki and approved by the Ethics Committee of The First Affiliated Hospital of Chengdu Medical College (approval number: 2025CYFYIRB-BA-023). The requirement for obtaining written informed consent was waived by the committee due to the retrospective nature of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}